Physician profile
Derrick S Tooth
NPI 1639260847
$685.19
in general payments reported to CMS, 2019-2025
11 companies · $58.09 in 2025
The $58.09 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.75 · 2020: $3.65 · 2021: $43.33 · 2022: $81.06 · 2023: $240 · 2024: $172 · 2025: $58.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $469.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih Ab | $183.01 | 2023-2025 | Lofric, Lofric |
| Pfizer INC. | $129.72 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $87.26 | 2021-2023 | Pylarify |
| Urogen Pharma, INC. | $81.38 | 2023-2024 | Jelmyto |
| Abbvie INC. | $55.04 | 2022-2023 | Botox |
| Boston Scientific Corporation | $40.01 | 2021-2024 | |
| Ambu INC. | $32.17 | 2020-2024 | |
| Sumitomo Pharma America, INC. | $23.89 | 2024 | Gemtesa |
| Urovant Sciences INC | $19.94 | 2022 | |
| Myriad Genetic Laboratories, INC. | $18.17 | 2023 | Prolaris |
| Ferring Pharmaceuticals INC. | $14.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Tooth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.